113,415 results on '"inflammatory bowel disease"'
Search Results
52. Histological scores are poor predictors of short term outcomes in acute severe ulcerative colitis: An observational study
53. Persistence of subcutaneous versus intravenous infliximab in a real-life cohort: A propensity-score matched comparative analysis
54. Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel disease
55. Geographical and sociodemographic epidemiology of inflammatory bowel disease in young females from 2010 to 2019
56. Risk of avascular necrosis in patients with inflammatory bowel disease: Insights from a nationwide cohort study and the impact of corticosteroid use
57. Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease
58. 20(S)-ginsenoside Rg3 alleviates DSS-induced colitis by promoting ERK-dependent maturation of MDSCs into M2 macrophages
59. De novo interleukin-10 production primed by Lactobacillus sakei CVL-001 amplifies the immunomodulatory abilities of mesenchymal stem cells to alleviate colitis
60. Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
61. Design, synthesis, and evaluation of quinolin-2(1H)-ones as PDE1 inhibitors for the treatment of inflammatory bowel disease
62. A review investigating delays in Crohn's disease diagnosis
63. Effects of Centella asiatica-isolated pectic polysaccharide on dextran sulfate sodium-induced colitis
64. The protective effect of amitriptyline on experimental colitis through inhibiting TLR-4/MD-2 signaling pathway
65. Rosavin derived from Rhodiola alleviates colitis in mice through modulation of Th17 differentiation
66. Caspase-4 Has Potential Utility as a Colorectal Tissue Biomarker for Dysplasia and Early-Stage Cancer
67. An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment
68. The development of artificial intelligence in the histological diagnosis of Inflammatory Bowel Disease (IBD-AI)
69. Vaccine adherence and adverse events of the SARS-COV vaccine in patients with inflammatory bowel disease
70. Evaluación de la calidad de vida de los pacientes con enfermedad inflamatoria intestinal
71. Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease
72. When metabolic comorbidities and risk of malnutrition coexist: The new era of inflammatory bowel disease
73. Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair
74. Evaluation of the potential use of protoporphyrins as biomarkers of anemic disease in human urine from inflammatory bowel disease patients
75. Impact of electro-acupuncture on EAAT2 and NMDAR-2B expression in goats with visceral hypersensitivity
76. Metabolomics for enhanced clinical understanding of inflammatory bowel disease
77. Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism
78. Genetically engineered bacteria as inflammatory bowel disease therapeutics
79. The roles of flavonoids in the treatment of inflammatory bowel disease and extraintestinal manifestations: A review
80. Exploring the relationship between Faecalibacterium duncaniae and Escherichia coli in inflammatory bowel disease (IBD): Insights and implications
81. Shikonin delivery nano system based on calcium alginate for targeted therapy of inflammatory bowel disease by modulating macrophage polarization
82. Bulk T cell repertoire sequencing (TCR-Seq) is a powerful technology for understanding inflammation-mediated diseases
83. Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
84. Model-informed precision dosing: State of the art and future perspectives
85. Optimization of alginate/carboxymethyl chitosan microbeads for the sustained release of celecoxib and attenuation of intestinal inflammation in vitro
86. Adverse childhood experiences and psychiatric comorbidity in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis in the Canadian longitudinal study on aging
87. Plasma bile acid profile analysis by liquid chromatography-tandem mass spectrometry and its application in healthy subjects and IBD patients
88. Therapeutic potential of tryptophan metabolite indoleacrylic acid in inflammatory bowel disease: From cellular mechanisms to zebrafish stress-like behavior
89. Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
90. Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/PPAR-γ/NF-κB/ROS signaling pathways
91. Potential of Glycyrrhiza in the prevention of colitis-associated colon cancer
92. Biological agents as attractive targets for inflammatory bowel disease therapeutics
93. Inflammatory bowel disease is associated with an increased risk of cardiovascular events in a sex and age-dependent manner: A historical cohort study
94. Autoimmune protocol diet: A personalized elimination diet for patients with autoimmune diseases
95. Early-life gut inflammation drives sex-dependent shifts in the microbiome-endocrine-brain axis
96. Tailored strategies based on polysaccharide structural and functional properties for nutrients delivery in inflammatory bowel disease
97. Selenium deficiency in inflammatory bowel disease: A comprehensive meta-analysis
98. Discovery of novel N2-indazole derivatives as phosphodiesterase 4 inhibitors for the treatment of inflammatory bowel disease
99. A review of inflammatory bowel disease from the perspective of Persian medicine
100. Histidine-derived carbon dots for redox modulation and gut microbiota regulation in inflammatory bowel disease therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.